Smoking dependency

SMOKING_DEPEND

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F17 Hospital discharge: ICD-9 — 3051 Cause of death: ICD-10 — F17 Cause of death: ICD-9 — 3051 2 out of 7 registries used, show all original rules.	3304
4. Check minimum number of events None	3304
5. Include endpoints None	3304
6. Filter based on genotype QC (FinnGen only)	3304

Control definitions (FinnGen only)

Control exclude: SMOKING

Extra metadata

First used in FinnGen datafreeze: DF12
Parent code in ICD-10: F10-F19
Name in latin: Perturbationes mentis et modi se gerendi ex usu tabaci

NAME	SMOKING_DEPEND
CONTROL_EXCLUDE	SMOKING
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F17
HD_ICD_9	3051
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F17
COD_ICD_9	3051
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Smoking dependency based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Mental and behavioural disorders due to tobacco

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20684	9243	11340
Only index persons	19695	8992	10703
Unadjusted period prevalence (%)
Whole population	0.29	0.26	0.32
Only index persons	0.37	0.33	0.41
Median age at first event (years)
Whole population	56.15	53.81	58.11
Only index persons	55.85	53.56	57.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3304	1718	1586
Unadjusted period prevalence (%)	0.64	0.59	0.70
Median age at first event (years)	56.10	53.46	58.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2848: Matched controls
28478

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N07BA03

ATC

varenicline; oral

11.9

323.3

637

674

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

1073.4

323.0

2006

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

12.3

323.0

927

1076

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3480.9

323.0

805

R03BB04

ATC

tiotropium bromide; inhalant

7.8

288.9

740

1219

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

800.1

228.5

222

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

12.5

223.2

422

392

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

184.9

1612

8256

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

10.9

174.9

351

361

Z72.0

ICD-10 Finland

Tobacco use

16.0

165.4

277

190

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.4

144.8

884

3344

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.4

138.9

460

982

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

11.4

136.1

265

253

R03AC02

ATC

salbutamol; inhalant

2.6

127.1

1770

11011

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.5

126.9

500

1278

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.0

125.6

375

702

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

122.0

799

3117

K05.31

ICD-10 Finland

Periodontitis pronounced

4.2

121.9

528

1474

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

418.2

121.6

121

XG410

NOMESCO Finland

Flow-volume spirometry

7.2

114.5

294

447

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

392.7

114.3

114

J45.9

ICD-10 Finland

Asthma, unspecified

3.2

112.0

721

2754

H02AB06

ATC

prednisolone; systemic

2.4

107.1

1552

9472

N06AX11

ATC

mirtazapine; oral

2.5

104.3

1119

5811

N05BA04

ATC

oxazepam; oral

2.7

102.4

892

4103

N05AH04

ATC

quetiapine; oral

3.1

102.0

689

2696

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.9

97.7

293

545

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.0

97.7

680

2706

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.9

96.2

254

399

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.4

94.3

379

970

N06AB04

ATC

citalopram; systemic

2.7

93.7

796

3575

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

93.2

536

1858

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.2

92.6

569

2068

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.3

90.4

534

1884

R06.0

ICD-10 Finland

Dyspnoea

2.6

89.7

831

3906

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.2

87.7

363

952

N02AX02

ATC

tramadol; systemic, rectal

2.2

87.3

1377

8436

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.7

86.9

320

748

N05CF01

ATC

zopiclone; oral

2.4

86.6

1043

5611

R95

ICPC

Chron obstructive pulmonary disease

8.3

84.8

196

251

P17

ICPC

Tobacco abuse

12.7

84.8

155

128

N06AX16

ATC

venlafaxine; oral

2.9

81.4

566

2218

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

9.8

79.9

167

180

C03CA01

ATC

furosemide; systemic

2.5

79.7

767

3643

N07BB01

ATC

disulfiram; oral

4.7

78.0

285

658

SPAT1254

SPAT

Administration of medicine

3.0

77.1

519

1985

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.6

75.9

206

334

N05CD07

ATC

temazepam; oral

3.1

75.9

463

1653

N05AA02

ATC

levomepromazine; systemic

5.0

75.9

258

551

EBA00

NOMESCO Finland

Extraction of tooth

2.2

75.2

1096

6342

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.7

74.9

360

1071

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

10.8

73.2

145

141

AA1AD

NOMESCO Finland

CT of head and brain

2.4

73.1

758

3716

N05BA01

ATC

diazepam; systemic, rectal

2.9

71.7

514

2038

SPAT1263

SPAT

Sampling

2.1

71.4

1305

8267

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

10.8

70.5

139

134

A02BC02

ATC

pantoprazole; systemic

2.0

68.2

1897

14099

N02BE01

ATC

paracetamol; systemic, rectal

2.5

68.1

2484

20816

J20

ICD-10 Finland

Acute bronchitis

3.2

68.0

391

1332

J01MA12

ATC

levofloxacin; systemic

2.5

67.3

640

2981

N05AH03

ATC

olanzapine; systemic

4.0

67.1

290

784

J01FF01

ATC

clindamycin; systemic

2.2

66.8

926

5173

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.2

65.6

185

315

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

65.3

1088

6561

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.6

65.1

322

976

N03AX16

ATC

pregabalin; oral

2.2

63.1

781

4125

M54.5

ICD-10 Finland

Low back pain

2.1

63.0

1047

6281

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

61.7

520

2255

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

59.7

1269

8330

N06AX12

ATC

bupropion; oral

3.8

59.1

270

764

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

17.8

58.8

R02

ICPC

Shortness of breath/dyspnoea

2.8

58.4

415

1618

SPAT1240

SPAT

Therapeutic discussion

2.8

58.2

415

1624

WZC30

NOMESCO Finland

Teaching

2.5

57.5

498

2185

E66.01

ICD-10 Finland

Obesity due to excess calories

3.2

57.4

324

1082

J01DB01

ATC

cefalexin; oral

2.2

56.0

2372

19870

SPAT1310

SPAT

Counselling related to known health issue

2.0

55.9

988

6000

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

55.6

860

4952

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

55.6

857

4931

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

55.1

1525

10885

J45.1

ICD-10 Finland

Nonallergic asthma

3.4

54.7

285

895

N05AX08

ATC

risperidone; systemic

3.4

54.2

285

901

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.3

54.0

150

250

XG466

NOMESCO Finland

Sleep oxymetry

5.2

53.7

176

359

N06AB03

ATC

fluoxetine; oral

2.6

53.7

450

1930

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

52.8

286

924

N02AA05

ATC

oxycodone; systemic

2.6

52.3

447

1936

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.0

51.9

816

4704

N03AX09

ATC

lamotrigine; oral

3.9

51.2

228

629

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.4

50.9

194

463

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.3

50.6

200

495

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

50.5

843

4963

G47.3

ICD-10 Finland

Sleep apnoea

2.1

50.4

725

4024

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

8.0

50.1

117

152

L03

ICPC

Low back symptom/complaint

2.1

50.0

734

4107

P15

ICPC

Chronic alcohol abuse

4.9

49.9

171

366

N06AB10

ATC

escitalopram; oral

2.1

49.6

645

3426

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.3

49.6

137

227

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.3

48.8

192

473

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

48.5

352

1381

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

9.4

48.3

102

112

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

47.9

416

1813

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

47.3

320

1201

N06AX21

ATC

duloxetine; oral

2.6

46.9

384

1615

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

46.8

631

3393

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.7

46.7

363

1484

WX110

NOMESCO Finland

Local anesthesy

1.8

46.5

1987

15933

J43.9

ICD-10 Finland

Emphysema, unspecified

9.0

46.2

100

115

L28

ICPC

Limited function/disability (L)

2.4

45.5

427

1933

C07AB07

ATC

bisoprolol; oral

1.8

45.5

1240

8595

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.5

45.1

222

665

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

44.9

413

1848

P01AB01

ATC

metronidazole; oral, rectal

1.8

44.7

1156

7862

N03AG01

ATC

valproic acid; systemic, rectal

3.2

44.4

249

822

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

4.0

44.0

186

489

M79.6

ICD-10 Finland

Pain in limb

1.8

43.9

1012

6619

J46

ICD-10 Finland

Status asthmaticus

5.4

43.6

135

258

J01AA02

ATC

doxycycline; systemic

1.9

43.5

2200

18397

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

43.4

426

1969

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

43.1

882

5532

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.0

42.7

109

162

J01MA14

ATC

moxifloxacin; systemic

2.7

42.6

325

1309

J96.1

ICD-10 Finland

Chronic respiratory failure

7.2

42.1

105

151

B01AC04

ATC

clopidogrel; oral

2.3

42.0

448

2156

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.2

42.0

117

196

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.4

41.8

113

182

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

41.8

1349

9765

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

41.7

206

618

S18

ICPC

Laceration/cut

1.7

41.7

1172

8132

R06.2

ICD-10 Finland

Wheezing

3.8

41.5

187

520

N05BA06

ATC

lorazepam; systemic, sublingual

3.7

41.5

192

546

R74

ICPC

Upper respiratory infection acute

1.9

41.3

829

5151

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.9

41.2

179

482

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.8

41.1

143

311

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

41.0

471

2344

N06AB06

ATC

sertraline; oral

2.4

40.6

368

1630

N05BA12

ATC

alprazolam; oral

2.5

40.5

354

1537

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.4

40.5

127

246

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

40.0

510

2656

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

39.9

742

4479

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.8

39.8

138

299

F10.24

ICD-10 Finland

Alcohol depence active use

6.8

39.7

103

157

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

39.7

983

6528

R03DA04

ATC

theophylline; systemic, rectal

3.8

39.6

176

484

R60.0

ICD-10 Finland

Localized oedema

2.5

39.4

334

1427

N05AF03

ATC

chlorprothixene; systemic

4.5

39.4

144

330

N05AX12

ATC

aripiprazole; systemic

3.9

39.3

171

461

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.1

39.0

160

409

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

38.9

180

512

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

38.8

239

841

N03AE01

ATC

clonazepam; systemic

3.1

38.7

227

773

S10

ICPC

Boil/carbuncle

3.2

38.3

213

699

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.3

38.2

133

H02AB04

ATC

methylprednisolone; systemic

2.2

38.1

452

2277

N03AX12

ATC

gabapentin; oral

2.1

38.1

480

2482

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

11.7

38.0

P29

ICPC

Psychological sympt/compl other

3.1

37.7

221

752

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

9.5

37.5

SPAT1301

SPAT

No procedures

1.8

37.3

873

5665

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

37.2

806

5099

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

37.1

608

3489

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

37.1

190

586

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

37.0

526

2858

J37.0

ICD-10 Finland

Chronic laryngitis

4.3

36.7

142

344

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

36.5

292

1207

F32

ICD-10 Finland

Depressive episode

3.1

36.4

208

695

N05BA02

ATC

chlordiazepoxide; systemic

4.7

36.3

127

278

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

35.9

298

1256

F61.0

ICD-10 Finland

Mixed personality disorders

6.3

35.8

161

J45

ICD-10 Finland

Asthma

2.5

35.8

316

1376

SPAT1234

SPAT

Support of social functional capacity

3.7

35.7

165

469

A06AD11

ATC

lactulose; oral

2.3

35.6

373

1770

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

35.3

387

1877

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

35.2

842

5481

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

35.1

603

3511

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

35.0

264

1054

K02.1

ICD-10 Finland

Caries of dentine

1.6

34.9

1621

12724

SPAT1283

SPAT

Restricted health certificate

2.0

34.8

544

3060

N06AB05

ATC

paroxetine; oral

2.8

34.7

233

866

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

34.4

323

1450

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

34.3

296

1272

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

34.1

293

1258

J01DA01

ATC

[U] cefalexin; systemic

1.6

33.8

1732

13900

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.4

33.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

33.5

1074

7596

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

33.4

774

4971

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

33.3

203

709

M79.1

ICD-10 Finland

Myalgia

2.2

33.2

393

1968

WX892

NOMESCO Finland

Monitored bed care

2.7

33.1

245

966

WX722

NOMESCO Finland

PEEP

3.2

33.0

184

604

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

32.5

1363

10330

SPAT1216

SPAT

Assessment of functional ability

2.1

32.2

394

2001

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

6.6

32.1

130

R96

ICPC

Asthma

2.5

32.0

276

1183

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

32.0

398

2034

SPAT1260

SPAT

Consultation of another employee

1.9

31.7

504

2840

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

31.7

1429

11006

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

31.6

330

1556

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

31.5

381

1925

A07AA02

ATC

nystatin; oral

3.0

31.4

196

694

N05AD01

ATC

haloperidol; systemic

4.2

31.3

124

308

H02AB07

ATC

prednisone; oral

2.1

31.2

417

2192

N05AB03

ATC

perphenazine; systemic, rectal

3.5

31.0

149

437

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

31.0

241

978

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.2

30.9

141

L17

ICPC

Foot/toe symptom/complaint

1.8

30.8

681

4291

SPAT1229

SPAT

Assessment of need for aid

2.7

30.7

220

848

WX290

NOMESCO Finland

Other blockade of nerve

1.6

30.6

1268

9528

N05BE01

ATC

buspirone; oral

3.9

30.6

132

354

T90

ICPC

Diabetes non-insulin dependent

1.8

30.5

618

3786

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

7.8

30.5

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.0

30.4

148

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

30.3

598

3631

R05

ICPC

Cough

1.8

29.8

613

3770

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.9

29.6

192

699

S06.0

ICD-10 Finland

Concussion

2.3

29.5

304

1426

SPAT1211

SPAT

Application of soft bandage

2.4

29.4

268

1181

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

29.3

1176

8731

M25.5

ICD-10 Finland

Pain in joint

1.7

29.3

792

5289

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

29.2

332

1628

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.5

29.0

161

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

29.0

446

2477

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.5

28.9

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

18.6

28.7

A10BA02

ATC

metformin; oral

1.7

28.7

716

4668

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

14.3

28.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.4

28.4

106

249

N06AA09

ATC

amitriptyline; systemic

2.2

28.3

298

1409

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

28.2

1075

7855

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

28.2

140

422

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

28.1

286

1332

N05AB01

ATC

dixyrazine; systemic

6.0

28.0

132

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.2

27.9

109

267

XQ800

NOMESCO Finland

Prick test

2.4

27.8

250

1094

R03BA05

ATC

fluticasone; inhalant

1.8

27.8

511

3019

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.9

27.6

118

314

K08.3

ICD-10 Finland

Retained dental root

2.5

27.6

234

994

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

27.4

697

4559

348

Kela drug reimbursment

Roflumilast

21.3

27.4

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

27.4

242

1052

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

27.2

287

1360

SPAT1235

SPAT

Mental health, emotional support

9.8

27.2

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

3.4

27.1

139

429

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

6.7

27.1

107

N05AN01

ATC

lithium; oral

4.3

27.0

103

247

E66.9

ICD-10 Finland

Obesity, unspecified

3.6

27.0

128

372

N05AH02

ATC

clozapine; systemic

4.7

27.0

206

V03AA01

ATC

4.5

26.9

220

R53

ICD-10 Finland

Malaise and fatigue

1.8

26.9

511

3048

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

16.1

26.7

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.2

26.6

R03AC03

ATC

terbutaline; inhalant

2.0

26.6

394

2152

J01FA06

ATC

roxithromycin; oral

1.6

26.6

1094

8115

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

26.5

598

3768

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

26.5

190

735

L02

ICPC

Back symptom/complaint

2.3

26.4

271

1264

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.6

26.4

198

785

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

26.3

258

1177

Z72.1

ICD-10 Finland

Alcohol use

5.8

26.3

135

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

10.6

26.2

R03AC18

ATC

indacaterol; inhalant

11.3

26.1

R51.80

ICD-10 Finland

Headache

1.9

26.0

412

2305

F34.1

ICD-10 Finland

Dysthymia

3.4

26.0

133

410

R03BA02

ATC

budesonide; inhalant

1.8

26.0

477

2812

C09AA05

ATC

ramipril; oral

1.7

25.9

600

3806

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.6

25.9

201

SPAT1312

SPAT

General health counselling

1.6

25.9

858

6015

SPAT1265

SPAT

Breathalyser

6.6

25.9

103

F17.9

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, unspecified mental and behavioural disorder

262.9

25.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

25.5

512

3105

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

25.5

123

363

K10.3

ICD-10 Finland

Alveolitis of jaws

2.9

25.4

163

589

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

25.4

487

2910

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

25.3

1086

8106

J45.8

ICD-10 Finland

Mixed asthma

3.6

25.1

117

336

R04.2

ICD-10 Finland

Haemoptysis

3.5

25.0

119

347

N06AX03

ATC

mianserin; oral

2.8

24.9

164

602

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

24.9

256

1194

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.4

24.9

210

A28

ICPC

Limited function/disability NOS

2.1

24.8

314

1607

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

24.8

249

1152

SPAT1227

SPAT

Substance abuse rehabilitation

7.8

24.7

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

9.1

24.7

N06AX05

ATC

trazodone; oral

3.9

24.7

105

279

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

24.7

325

1691

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

24.6

130

411

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.8

24.6

126

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.2

24.2

109

ZYC01

SPAT

2.6

24.1

189

769

A01

ICPC

Pain general/multiple sites

2.4

24.1

216

944

R03AK08

ATC

formoterol and beclometasone; inhalant

3.1

24.1

134

440

SPAT1262

SPAT

Handing over of treatment supplies

1.8

24.1

494

3014

P76

ICPC

Depressive disorder

2.5

24.1

203

858

M54

ICD-10 Finland

Dorsalgia

2.0

24.1

321

1680

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

24.1

648

4282

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

24.0

667

4447

SPAT1059

SPAT

Spirometry at the office

2.7

24.0

169

645

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

23.9

341

1832

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

23.8

685

4613

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

23.8

249

1174

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

23.7

221

985

S22.3

ICD-10 Finland

Fracture of rib

2.5

23.7

201

853

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

23.7

188

769

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.1

23.6

149

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.2

23.6

145

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

23.6

105

290

A04

ICPC

Weakness/tiredness general

2.0

23.6

309

1603

X58

ICD-10 Finland

Exposure to other specified factors

1.9

23.5

402

2308

EBA30

NOMESCO Finland

Excision of root of tooth

2.6

23.5

177

703

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

23.8

23.5

P16

ICPC

Acute alcohol abuse

4.6

23.5

181

WX882

NOMESCO Finland

High dependency care

3.8

23.4

100

267

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

23.4

442

2622

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

23.3

1515

12320

N04AA02

ATC

biperiden; systemic

4.1

23.2

225

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

23.2

277

1384

S97

ICPC

Chronic ulcer skin

2.7

23.1

162

618

A46

ICD-10 Finland

Erysipelas

1.9

23.1

370

2074

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

23.0

1924

16495

R03DX07

ATC

roflumilast; oral

20.2

23.0

3051A

ICD-9 Finland

Nondependent abuse of drugs, Tobacco use disorder

+∞

22.9

D11

ICPC

Diarrhoea

2.0

22.9

304

1584

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.0

22.6

138

483

P72

ICPC

Schizophrenia

4.5

22.6

188

L08

ICPC

Shoulder symptom/complaint

1.7

22.6

491

3043

K05.3

ICD-10 Finland

Chronic periodontitis

2.6

22.5

172

689

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

22.5

519

3274

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

22.5

671

4548

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

22.5

103

292

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

22.5

457

2773

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

22.4

585

3820

T74.1

ICD-10 Finland

Physical abuse

4.3

22.4

204

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.0

22.4

105

N05AA01

ATC

chlorpromazine; systemic, rectal

5.4

22.4

129

R03DC03

ATC

montelukast; oral

1.8

22.2

437

2623

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

22.2

407

2388

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

22.1

349

1944

WZA90

NOMESCO Finland

Other doctors statement

1.6

22.0

620

4134

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

21.9

310

1657

K04.0

ICD-10 Finland

Pulpitis

2.0

21.8

294

1543

SPAT1058

SPAT

PEF monitoring instruction

2.2

21.7

230

1087

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

18.5

21.7

SPAT1153

SPAT

Removal of sutures

1.6

21.7

823

5914

G44.2

ICD-10 Finland

Tension-type headache

1.9

21.7

364

2070

A02BC01

ATC

omeprazole; systemic

1.6

21.5

694

4792

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

21.4

226

1068

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

21.2

502

3182

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

14.7

21.1

J01CA04

ATC

amoxicillin; systemic

1.5

21.1

2196

19533

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

21.1

228

1090

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

21.1

178

753

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

21.0

192

847

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.1

20.9

203

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.7

20.8

107

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.8

20.7

150

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

20.6

534

3473

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

20.6

130

466

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

20.5

432

2646

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

20.5

229

1110

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.1

20.4

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

22.5

20.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

20.3

300

1627

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.8

20.3

132

481

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.2

20.2

109

351

UJF32

NOMESCO Finland

Coloscopy

1.6

20.1

627

4281

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

20.1

226

1099

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.7

20.0

151

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

13.7

20.0

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.9

19.9

121

423

M03BX02

ATC

tizanidine; oral

1.4

19.8

1698

14381

E000001

ATC

1.6

19.7

536

3531

R03BA01

ATC

beclometasone; inhalant

1.8

19.6

378

2250

130

Kela drug reimbursment

Malignant tumour

2.1

19.6

225

1104

SPAT1247

SPAT

Outpatient detoxication and monitoring

10.4

19.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.5

19.6

159

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

19.6

267

1406

P99

ICPC

Psychological disorders other

3.3

19.6

100

310

H25.8

ICD-10 Finland

Other senile cataract

2.2

19.5

215

1035

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

19.5

219

1063

D82

ICPC

Teeth/gum disease

1.5

19.5

905

6770

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

19.5

243

1234

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

19.4

149

599

Z72.2

ICD-10 Finland

Drug use

10.7

19.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

19.3

548

3651

C07AA05

ATC

propranolol; systemic

1.6

19.2

510

3334

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.0

19.2

245

1255

Z00.0

ICD-10 Finland

General medical examination

1.7

19.2

472

3022

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.6

19.1

241

R03AC13

ATC

formoterol; inhalant

2.5

19.1

152

625

P74

ICPC

Anxiety disorder/anxiety state

2.9

19.1

121

435

F31

ICD-10 Finland

Bipolar affective disorder

5.0

19.0

124

E0000UV

ATC

1.5

19.0

1009

7758

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.0

18.9

193

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.0

18.9

189

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.3

18.9

297

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

18.8

153

636

P03

ICPC

Feeling depressed

2.0

18.8

251

1309

ZXH06

SPAT

3.5

18.8

255

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

18.8

107

357

JN4BD

NOMESCO Finland

Extensive body CT

1.9

18.7

289

1591

M05BA04

ATC

alendronic acid; oral

2.3

18.7

174

773

M01AE02

ATC

naproxen; oral, rectal

1.4

18.7

1503

12509

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

18.7

580

3945

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

18.6

533

3551

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

18.6

142

570

ICB03

SPAT

23.8

18.6

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.3

18.6

110

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

4.3

18.5

164

R07.3

ICD-10 Finland

Other chest pain

2.0

18.5

248

1295

XQ802

NOMESCO Finland

Epicutan test

2.7

18.3

132

511

C10AA05

ATC

atorvastatin; oral

1.5

18.3

901

6802

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

18.3

178

810

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.6

18.3

138

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

18.3

459

2948

L12

ICPC

Hand/finger symptom/complaint

1.8

18.2

347

2056

I50.0

ICD-10 Finland

Congestive heart failure

2.6

18.1

138

554

A02BC05

ATC

esomeprazole; systemic

1.4

18.0

1027

7981

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

18.0

247

1304

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

18.0

272

1488

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

15.4

17.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

17.9

120

447

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

17.9

158

683

TGC00

NOMESCO Finland

Bronchial lavation

3.4

17.9

266

L73.2

ICD-10 Finland

Hidradenitis suppurativa

5.6

17.8

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.9

17.8

109

384

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.3

17.8

169

762

S76

ICPC

Skin infection other

2.4

17.7

151

642

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.2

17.7

290

A01AB09

ATC

miconazole; local oral

2.1

17.5

218

1106

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

6.9

17.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

17.4

284

1595

A77

ICPC

Viral disease other/NOS

2.8

17.4

115

425

JN4AD

NOMESCO Finland

Body CT examination

2.1

17.4

213

1075

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

3.4

17.3

257

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.4

17.2

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.1

17.2

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

3.4

17.2

258

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

17.2

136

558

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

9.8

17.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

17.1

716

5209

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

17.1

243

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

17.1

272

1513

E87.6

ICD-10 Finland

Hypokalaemia

3.1

17.1

323

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

17.1

511

3437

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

17.1

475

3136

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

17.0

150

650

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.4

17.0

249

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

17.0

1859

16236

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.1

16.9

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

9.5

16.9

Z04.3

ICD-10 Finland

Examination and observation following other accident

3.5

16.8

225

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

16.8

139

581

R42

ICD-10 Finland

Dizziness and giddiness

1.6

16.8

491

3282

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

16.8

229

1203

R63.4

ICD-10 Finland

Abnormal weight loss

3.0

16.8

335

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

6.0

16.8

C08CA01

ATC

amlodipine; oral

1.5

16.7

804

6016

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

5.0

16.7

107

WZC00

SPAT

2.5

16.7

129

521

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.1

16.5

104

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.6

16.5

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

16.5

276

1564

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.9

16.4

101

357

F41.00

ICD-10 Finland

Moderate panic disorder

4.4

16.4

136

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

7.5

16.4

T82

ICPC

Obesity

2.7

16.4

113

428

E66.8

ICD-10 Finland

Other obesity

2.3

16.4

152

678

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

16.3

1008

7913

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

5.6

16.3

K03.66

ICD-10 Finland

Tooth plaque

2.2

16.3

169

794

N03AF01

ATC

carbamazepine; oral, rectal

2.3

16.3

148

653

R03AC12

ATC

salmeterol; inhalant

2.6

16.2

117

456

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

16.2

229

1221

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.2

16.2

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

16.2

158

721

R32

ICD-10 Finland

Unspecified urinary incontinence

3.5

16.2

222

R03AC19

ATC

olodaterol; inhalant

15.4

16.2

P01

ICPC

Feeling anxious/nervous/tense

1.9

16.2

259

1445

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.4

16.1

228

N06AA12

ATC

doxepin; systemic

2.3

16.1

154

694

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

16.1

1073

8544

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

16.0

344

2109

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.8

16.0

112

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.4

16.0

135

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

16.0

106

391

W19

ICD-10 Finland

Unspecified fall

1.9

16.0

239

1303

D73

ICPC

Gastroenteritis presumed infection

3.0

15.9

318

N05AC02

ATC

thioridazine; oral

3.4

15.9

230

OAB42

SPAT

2.4

15.9

140

607

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

6.9

15.9

N06AX26

ATC

vortioxetine; oral

2.3

15.9

150

673

IGY02

SPAT

7.7

15.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

15.8

222

1181

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

15.8

332

2021

D10

ICPC

Vomiting

2.3

15.8

150

675

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

15.7

162

758

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

15.7

129

538

J96.0

ICD-10 Finland

Acute respiratory failure

5.6

15.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

15.7

139

606

M48.0

ICD-10 Finland

Spinal stenosis

1.8

15.7

273

1566

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

15.7

124

510

WW200

SPAT

1.8

15.5

287

1679

L16

ICPC

Ankle symptom/complaint

1.9

15.5

253

1421

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

5.1

15.4

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

15.4

251

1405

R03BB07

ATC

umeclidinium bromide; inhalant

6.2

15.4

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.4

15.4

220

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.4

15.4

226

XG405

NOMESCO Finland

Education on PEF monitoring

4.1

15.4

150

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

12.4

15.3

R03BB06

ATC

glycopyrronium bromide; inhalant

12.4

15.3

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

15.3

362

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

15.2

191

974

K04.09

ICD-10 Finland

Pulpit UNS

2.5

15.2

120

492

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

15.2

186

938

C10AA01

ATC

simvastatin; oral

1.4

15.2

969

7629

N05BB01

ATC

hydroxyzine; systemic

2.2

15.2

165

789

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.7

15.1

182

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.5

15.1

208

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

15.1

113

450

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

15.1

119

486

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.5

15.0

120

497

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

6.8

15.0

P19

ICPC

Drug abuse

5.9

14.9

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.9

14.9

159

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.4

14.9

133

580

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

12.5

14.8

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.4

14.8

122

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.3

14.8

127

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

14.8

371

2377

R51

ICD-10 Finland

Headache

2.3

14.7

140

631

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

9.2

14.7

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.8

14.7

280

1656

Z51.5

ICD-10 Finland

Palliative care

2.3

14.6

134

593

SPAT1172

SPAT

Guidance concerning hydration

4.3

14.6

124

N01

ICPC

Headache

1.8

14.6

242

1365

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

14.5

234

1308

W0A10

NOMESCO Finland

Mapping of psychosocial situation

15.4

14.4

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

14.4

150

705

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

14.3

124

535

N05CF02

ATC

zolpidem; oral

1.6

14.3

444

3001

GDC00

NOMESCO Finland

Lobectomy of lung

8.2

14.2

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.1

14.2

132

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

6.1

14.2

C03DA01

ATC

spironolactone; oral

1.8

14.2

232

1304

S01.0

ICD-10 Finland

Open wound of scalp

1.9

14.2

199

1057

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

7.0

14.1

R13

ICD-10 Finland

Dysphagia

2.1

14.1

162

795

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

14.1

370

UKC02

NOMESCO Finland

Cystoscopy

1.6

13.9

367

2381

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.5

13.9

112

465

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

4.8

13.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

13.9

144

675

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

13.9

923

7293

N06AA10

ATC

nortriptyline; systemic

3.2

13.8

234

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

4.4

13.8

112

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

13.8

264

1562

IEV99

SPAT

23.9

13.8

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

11.5

13.8

J42

ICD-10 Finland

Unspecified chronic bronchitis

4.8

13.7

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

13.7

167

841

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

13.7

278

1671

N06AB08

ATC

fluvoxamine; oral

2.8

13.7

326

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.0

13.6

179

930

D07AC01

ATC

betamethasone; topical

1.4

13.6

835

6496

R28

ICPC

Limited function/disability (R)

4.5

13.6

105

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.7

13.6

163

P06

ICPC

Sleep disturbance

1.8

13.6

246

1430

WX002

NOMESCO Finland

Sedation and analgesia

1.5

13.6

460

3173

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

6.6

13.5

R52.9

ICD-10 Finland

Pain, unspecified

1.9

13.5

204

1115

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

13.5

116

498

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

13.5

167

845

N05AF05

ATC

zuclopenthixol; systemic

4.3

13.5

115

R03BA08

ATC

ciclesonide; inhalant

1.9

13.5

211

1169

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

13.5

100

398

IHZ05

SPAT

3.5

13.4

175

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.9

13.4

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.9

13.4

290

N05AF01

ATC

flupentixol; systemic

3.5

13.3

176

D07AB08

ATC

desonide; topical

1.8

13.3

254

1500

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

13.3

1376

11669

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.8

13.3

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.1

13.3

147

710

SBA00

NOMESCO Finland

Microbiological examinations

2.9

13.2

285

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

13.2

238

1381

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

13.2

149

724

SPAT1272

SPAT

Drug screening

8.6

13.2

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

7.3

13.2

A08

ICPC

Swelling

2.5

13.2

397

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.2

13.2

215

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.2

13.2

K92.0

ICD-10 Finland

Haematemesis

3.1

13.2

232

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

13.1

139

658

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

13.1

104

429

R52.2

ICD-10 Finland

Other chronic pain

2.5

13.1

100

403

R03BB01

ATC

ipratropium bromide; inhalant

2.8

13.1

312

R11

ICD-10 Finland

Nausea and vomiting

1.9

13.0

184

981

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

13.0

124

562

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

11.0

13.0

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

13.0

150

739

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

5.4

13.0

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

16.8

13.0

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

16.8

13.0

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

12.9

171

888

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.9

12.9

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.4

12.9

609

4506

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.8

12.9

145

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

12.9

122

548

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

12.9

114

497

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

12.9

185

995

L01

ICPC

Neck symptom/complaint

1.6

12.8

330

2122

WX320

NOMESCO Finland

Spinalanesthesy

1.5

12.8

533

3842

D01

ICPC

Abdominal pain/cramps general

1.8

12.8

248

1470

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

12.8

241

1420

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.3

12.7

A99

ICPC

Disease/condition unspecnature/site

1.9

12.7

193

1057

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

3.2

12.7

216

SPAT1285

SPAT

Provision of consultation response

2.1

12.7

136

650

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.9

12.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

6.5

12.6

H66.9

ICD-10 Finland

Otitis media, unspecified

2.2

12.6

131

618

R05

ICD-10 Finland

Cough

1.5

12.6

453

3167

L86

ICPC

Back syndrome with radiating pain

2.1

12.5

145

716

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

5.7

12.5

E86

ICD-10 Finland

Volume depletion

3.4

12.5

175

ZYY01

SPAT

20.1

12.4

V03AB30

ATC

5.0

12.4

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.2

12.4

208

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.3

12.4

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

12.4

148

739

R78

ICPC

Acute bronchitis/bronchiolitis

3.0

12.4

240

D07AC13

ATC

mometasone; topical

1.4

12.4

712

5461

A03

ICPC

Fever

1.6

12.4

389

2633

309

Kela drug reimbursment

Nalmefene and naltrexone

7.6

12.4

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

12.4

137

665

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.8

12.4

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

12.3

242

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

12.3

663

5023

J43.2

ICD-10 Finland

Centrilobular emphysema

11.7

12.3

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

12.3

131

624

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

7.1

12.3

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.9

12.2

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

5.7

12.2

P18

ICPC

Medication abuse

6.7

12.2

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.6

12.2

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

12.1

329

2145

IGY99

SPAT

6.4

12.1

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

12.1

290

30041

ICD-8 Finland

Neuroses, Depressiva

4.7

12.1

L09

ICPC

Arm symptom/complaint

2.3

12.1

107

469

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.8

12.1

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

12.0

219

1276

F41.01

ICD-10 Finland

Severe panic disorder

8.2

12.0

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

3.6

12.0

149

N05AL01

ATC

sulpiride; systemic

3.6

12.0

149

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

12.0

300

N06AG02

ATC

moclobemide; oral

2.2

12.0

117

536

B01AB05

ATC

enoxaparin; parenteral

1.4

12.0

694

5325

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.5

11.9

155

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

11.9

302

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.4

11.9

166

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.1

11.9

204

OAA68

SPAT

7.6

11.9

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.8

11.9

266

R81

ICPC

Pneumonia

2.6

11.8

321

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

4.3

11.8

102

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.3

11.8

102

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

7.1

11.8

OAB43

SPAT

0.6

11.8

186

2992

UJD02

NOMESCO Finland

Gastroscopy

2.2

11.8

117

539

K02

ICD-10 Finland

Dental caries

1.9

11.7

185

1025

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

9.0

11.7

B86

ICD-10 Finland

Scabies

3.4

11.7

163

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.5

11.7

352

J96.9

ICD-10 Finland

Respiratory failure, unspecified

7.4

11.7

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.2

11.7

185

F05.9

ICD-10 Finland

Delirium, unspecified

3.6

11.6

143

A02BA02

ATC

ranitidine; systemic

1.5

11.6

443

3128

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

4.7

11.6

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.2

11.6

186

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.1

11.6

197

F40.1

ICD-10 Finland

Social phobias

3.0

11.6

223

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

11.5

348

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

11.5

176

966

M01AB05

ATC

diclofenac; systemic, rectal

1.3

11.5

1747

15528

OAB40

SPAT

11.1

11.5

M70.2

ICD-10 Finland

Olecranon bursitis

2.4

11.5

414

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.6

11.5

332

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.4

11.5

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

11.4

354

2383

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.7

11.4

130

IHZ04

SPAT

7.5

11.4

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.5

11.4

151

SPD01

NOMESCO Finland

Mucosa-supported complete denture

5.0

11.4

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.8

11.3

126

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

7.0

11.3

SPAT1238

SPAT

Brief therapy

3.1

11.3

195

K59.0

ICD-10 Finland

Constipation

2.1

11.3

124

599

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

8.3

11.3

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

11.3

227

1363

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

11.2

152

799

R50.9

ICD-10 Finland

Fever, unspecified

1.6

11.2

330

2196

Z01.2

ICD-10 Finland

Dental examination

1.3

11.2

1012

8329

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

11.2

376

2580

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.9

11.2

224

SPE01

NOMESCO Finland

Mucosa-supported partial denture

3.5

11.2

148

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.2

11.2

113

525

K04.08

ICD-10 Finland

Other specified pulpit

1.9

11.2

165

895

N05AE04

ATC

ziprasidone; systemic

5.7

11.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

6.8

11.1

L15

ICPC

Knee symptom/complaint

1.5

11.1

458

3288

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

11.1

176

981

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

11.1

295

1915

SPAT1104

SPAT

Monitoring of emergency patient

1.9

11.0

164

891

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

11.0

358

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.5

11.0

358

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

11.0

115

545

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.0

11.0

214

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

11.0

703

5473

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.7

11.0

287

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.8

11.0

257

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

10.9

252

1575

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

4.2

10.9

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

10.9

406

2852

UJC02

NOMESCO Finland

Rigid oesophagoscopy

5.3

10.9

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

10.8

230

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.9

10.8

218

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

8.3

10.8

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.3

10.8

100

446

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

6.5

10.8

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

10.6

10.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

10.7

166

918

R33

ICD-10 Finland

Retention of urine

1.9

10.7

158

859

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.7

566

4259

WYA20

NOMESCO Finland

Home visit

4.4

10.7

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.1

10.7

R55

ICD-10 Finland

Syncope and collapse

1.7

10.7

230

1408

M79.7

ICD-10 Finland

Fibromyalgia

2.4

10.7

370

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.9

10.7

108

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.3

10.7

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

10.7

115

553

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.4

10.6

354

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

10.6

112

533

SPAT1097

SPAT

Recording of ECG

1.5

10.6

326

2193

A02BA04

ATC

nizatidine; systemic

1.8

10.6

177

1004

SPAT1255

SPAT

Intravenous administration of medicine

1.9

10.5

158

861

L14

ICPC

Leg/thigh symptom/complaint

1.9

10.5

162

892

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

8.5

10.5

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

10.5

173

976

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.9

10.5

211

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.8

10.5

167

931

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.4

10.5

151

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

10.5

131

668

L76

ICPC

Fracture: other

2.8

10.5

247

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.9

10.4

224

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.7

10.4

257

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

10.4

124

620

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

10.4

155

846

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

10.4

268

1727

L13

ICPC

Hip symptom/complaint

1.5

10.3

326

2204

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.6

10.3

284

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

10.3

214

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.8

10.3

237

TUPEI

NOMESCO Finland

0.2

10.3

476

R29

ICPC

Respiratory symptom/complaint other

1.9

10.3

152

825

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.6

10.3

127

N06BA04

ATC

methylphenidate; oral

3.0

10.3

192

R06AE07

ATC

cetirizine; oral

1.3

10.3

1056

8828

A01AB04

ATC

amphotericin B; local oral

2.2

10.3

107

506

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

5.5

10.2

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

10.2

230

1426

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

10.2

159

880

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

10.2

188

1102

TUPKY

NOMESCO Finland

4.6

10.2

I20.09

ICD-10 Finland

Unstable angina

2.1

10.2

118

585

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.4

10.1

139

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

2.0

10.1

120

601

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.1

10.1

172

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.9

10.1

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.0

10.1

199

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

10.1

243

1535

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.8

10.1

218

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.1

562

4269

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

10.0

259

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.0

897

7341

S29

ICPC

Skin symptom/complaint other

1.5

10.0

373

2616

J01CF05

ATC

flucloxacillin; systemic

2.2

10.0

439

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022313) Gas panel - Capillary blood

553

1114

5.76

267.22

5.0

3.5

—

(3009343) pH of Capillary blood

646

1548

4.94

255.21

4.9

3.4

7.4

0.92

202

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

649

1572

4.89

252.93

5.0

3.4

5.4

5.1

kpa

6.49

609

1459

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

628

1488

4.98

251.28

4.9

3.4

1.7

mmol/l

0.05

509

1108

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

493

968

5.81

244.03

5.2

3.7

24.9

24.8

mmol/l

0.24

467

901

(3019225) pH of Specimen

776

2524

3.71

199.58

5.1

4.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

884

3273

3.32

184.00

4.8

4.3

29.9

31.8

4.90

627

2263

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1967

11720

2.68

162.16

9.0

6.0

1.2

mmol/l

0.33

1774

10671

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1300

6575

2.61

146.58

2.9

2.3

—

(3023368) Bacteria identified in Blood by Culture

1334

6946

2.54

140.11

4.7

4.4

—

(42870588) Differential panel, method unspecified - Blood

1589

9158

2.42

131.29

6.8

6.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

899

4078

2.65

123.17

2.2

1.8

—

(3013512) EKG study

1381

7644

2.39

122.95

4.5

3.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1640

9870

2.31

119.00

4.7

3.3

67.8

47.7

ng/l

0.37

1215

6437

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2101

14045

2.36

118.68

7.1

6.3

9.0

11.5

umol/l

18.20

1984

13371

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

375

1071

3.82

113.24

2.2

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2266

15838

2.37

112.50

6.6

4.8

6.8

6.7

mmol/l

1.63

2158

14814

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1457

8499

2.28

111.97

3.4

2.6

51.8

58.3

u/l

7.90

1324

7893

(3044640) Blood type and Crossmatch panel - Blood

1462

8548

2.27

111.63

3.0

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

977

3.89

109.09

2.1

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

319

841

4.09

107.64

3.4

2.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

808

3694

2.57

107.08

2.4

1.8

1.7

1.5

13.55

687

3293

(3013115) Eosinophils [#/volume] in Blood

2079

14222

2.25

105.47

7.5

6.2

0.2

e9/l

3.51

1863

12574

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1936

12896

2.21

104.61

8.8

6.8

1.2

mmol/l

0.21

1665

10919

(3001604) Monocytes [#/volume] in Blood

2016

13683

2.21

103.41

7.1

5.9

0.7

0.6

e9/l

31.79

1825

11907

(3006315) Basophils [#/volume] in Blood

2022

13747

2.21

103.18

7.1

6.0

0.0

e9/l

20.28

1829

11953

(4010399)

509

1905

2.98

98.83

1.5

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

2038

14098

2.16

96.77

7.2

6.0

2.1

1.9

e9/l

2.60

1839

12506

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1213

6913

2.19

94.89

3.3

2.9

1587.7

1136.8

ng/l

2.44

1010

5853

(3013650) Neutrophils [#/volume] in Blood by Automated count

2202

15876

2.16

91.47

11.3

9.2

4.9

4.1

e9/l

53.70

2019

13919

(3032080) INR in Blood by Coagulation assay

1622

10523

2.06

88.39

6.3

8.5

1.1

1.2

inr

2.97

353

3101

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2683

21095

2.45

88.11

10.0

7.6

80.3

77.2

u/l

3.52

2540

19951

(3019309) Folate [Moles/volume] in Red Blood Cells

861

4394

2.30

87.04

1.9

1.7

1039.6

1167.5

nmol/l

4.01

641

3369

(3019060) Gas panel - Arterial blood

456

1718

2.92

86.87

6.1

5.1

—

(3019069) Monocytes/100 leukocytes in Blood

1871

12862

2.05

86.00

7.6

6.4

8.2

8.6

5.59

1749

12107

(3006504) Eosinophils/100 leukocytes in Blood

1854

12782

2.03

83.59

7.1

6.2

2.6

2.9

5.66

1719

11967

(3003396) Base excess in Arterial blood by calculation

649

2980

2.47

83.03

8.2

7.9

1.4

1.0

mmol/l

1.76

553

2317

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

649

2997

2.45

81.90

8.3

7.8

5.5

5.1

kpa

11.42

625

2864

(3027801) Oxygen [Partial pressure] in Arterial blood

649

2998

2.45

81.83

8.3

7.8

10.2

12.5

kpa

31.42

628

2865

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1299

7981

2.03

80.05

2.5

2.2

252.4

224.7

u/l

0.21

1220

7520

(3002030) Lymphocytes/100 leukocytes in Blood

1889

13236

2.00

79.84

7.3

6.2

25.9

28.3

18.21

1738

12403

(3022096) Basophils/100 leukocytes in Blood

1795

12419

1.98

77.97

7.2

6.2

0.7

0.57

1666

11640

(3028707) Methadone [Presence] in Urine by Screen method

191

434

4.61

77.82

7.5

2.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1855

13068

1.96

75.41

7.0

6.0

59.6

56.9

18.70

1724

12296

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

381

1429

2.88

72.61

1.9

1.6

—

(3016502) Oxygen saturation in Arterial blood

581

2691

2.41

72.05

8.6

8.3

93.6

95.8

11.69

567

2592

(3014111) Lactate [Moles/volume] in Serum or Plasma

518

2287

2.50

71.30

7.1

7.4

1.4

mmol/l

0.91

497

2207

(3012095) Magnesium [Moles/volume] in Serum or Plasma

808

4360

2.13

68.93

3.6

0.8

mmol/l

2.72

745

4116

(4034850)

275

889

3.28

67.69

11.1

9.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

276

897

3.27

67.34

2.2

2.5

470.2

510.0

ug/l

0.10

257

847

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

359

1363

2.83

66.67

7.7

10.4

24.9

24.2

mmol/l

3.40

320

1287

(3024561) Albumin [Mass/volume] in Serum or Plasma

1638

11378

1.87

66.23

5.3

5.0

34.4

35.8

g/l

18.36

1500

10639

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

153

332

4.78

65.87

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

217

661

3.44

58.60

10.0

2.9

—

(3000991) Gas panel - Venous blood

467

2142

2.37

58.36

9.4

8.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

653

3442

2.12

58.09

7.0

6.3

1.0

mmol/l

0.32

599

3232

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

525

2541

2.27

57.84

2.5

2.3

0.2

g/l

0.19

487

2382

(3021960) Folate [Moles/volume] in Serum or Plasma

951

5753

1.92

57.20

1.6

1.5

18.7

20.6

nmol/l

2.00

768

4982

(3042936) Bacteria identified in Isolate by Culture

705

3847

2.06

57.06

2.4

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

136

303

4.64

56.66

2.4

2.3

31.8

22.6

mg/l

0.92

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

8.83

56.53

2.2

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1767

12955

1.78

56.29

4.5

4.1

—

(3002032) Base excess in Venous blood by calculation

487

2309

2.30

56.25

5.5

3.7

2.2

1.9

mmol/l

0.78

413

1868

(3020891) Body temperature

286

1054

2.88

55.84

10.0

4.5

—

(3002385) Erythrocyte distribution width [Ratio]

1897

23355

0.56

55.34

26.4

16.2

14.1

13.6

38.93

1866

22873

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1493

10482

1.77

54.67

2.2

1.9

97.3

95.7

pmol/l

0.55

881

5594

(3013707) Erythrocyte sedimentation rate by Westergren method

2479

20223

1.90

54.32

5.1

4.0

14.1

11.3

mm/h

15.90

2276

18823

(3008757) Leukocyte morphology finding [Identifier] in Blood

127

277

4.73

54.30

2.3

4.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

482

2312

2.27

54.02

5.6

3.7

6.2

5.8

kpa

9.24

467

2242

(3003338) MCHC [Mass/volume]

1985

24048

0.56

52.97

29.6

16.9

331.7

333.0

g/l

8.85

1969

23898

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

348

1462

2.54

52.42

1.8

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

226

764

3.10

51.37

7.0

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

405

1866

2.33

49.68

4.6

2.9

4.8

4.6

kpa

0.60

388

1804

(3031040) Bacteria [#/volume] in Urine by Automated count

2198

17492

1.77

49.63

5.6

4.1

289.3

1333.4

e6/l

1.51

222

(3007853) Bacteria identified in Skin by Aerobe culture

584

3148

2.04

48.07

2.2

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

1248

8549

1.74

48.03

4.5

3.2

7.4

7.9

mmol/l

3.52

1008

7276

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

296

4.31

47.33

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

124

296

4.31

47.33

1.6

1.5

—

(4015189)

9.06

47.25

2.4

2.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

144

386

3.86

46.97

1.4

26.3

26.5

u/l

0.02

109

313

(3005988) Vibrio sp identified in Specimen by Organism specific culture

124

298

4.28

46.92

1.6

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

299

4.27

46.72

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

591

3234

2.01

46.51

18.9

22.4

1.1

1.3

inr

4.08

478

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

125

305

4.22

46.37

1.6

1.5

—

(3042631) Mycobacterium sp identified in Specimen

130

334

4.01

44.99

3.2

2.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

123

304

4.16

44.85

1.6

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

989

6462

1.76

44.19

2.4

2.1

3.2

2.9

mg/l

3.45

812

5534

(3004616) Nuclear Ab [Presence] in Serum

131

344

3.92

43.98

1.5

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

596

3332

1.96

43.87

9.8

7.3

103.1

104.5

mmol/l

7.39

586

3267

(1761868) Lipid panel - Serum or Plasma

673

10644

0.54

43.81

2.7

—

(3016879) Cocaine [Presence] in Urine

238

914

2.73

42.76

7.0

2.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

481

2516

2.07

42.60

2.3

2.2

364.3

370.5

nmol/l

0.22

433

2331

(3017732) Neutrophils [#/volume] in Blood

393

1928

2.18

41.07

2.8

3.0

5.0

4.1

e9/l

6.86

233

1550

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

577

3288

1.91

39.78

5.8

6.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

138

406

3.50

39.23

6.5

5.5

365.3

364.3

umol/l

0.03

127

361

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2303

19103

1.68

39.18

5.2

3.1

65.3

48.4

u/l

7.70

2128

17958

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

524

2911

1.95

38.91

2.7

4.5

225.1

245.5

u/l

3.08

474

2770

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

249

1025

2.55

38.85

2.1

1.6

1.9

ug/l

0.13

224

925

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

504

2770

1.97

38.60

2.1

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

449

2371

2.03

38.51

8.7

8.0

8.7

9.4

mmol/l

1.46

429

2272

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

333

3.73

38.00

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

238

984

2.53

36.76

7.1

2.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

247

4.14

36.51

2.3

4.0

58.4

56.5

0.31

165

(3015235) Bicarbonate [Moles/volume] in Capillary blood

177

636

2.88

36.00

3.8

3.0

25.9

24.8

mmol/l

2.18

159

554

(3028300) Cannabinoids [Presence] in Urine

238

996

2.50

35.82

7.1

2.0

—

(3027008) Opiates [Presence] in Urine

237

991

2.50

35.73

7.0

2.0

—

(3042517) Benzodiazepines panel - Urine

15.64

35.71

2.6

2.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

234

4.15

34.82

1.5

1.4

1.5

1.3

promille

0.59

181

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

261

1154

2.37

34.79

4.6

2.6

0.7

0.42

248

1103

(3018405) Lactate [Moles/volume] in Arterial blood

225

936

2.51

34.27

8.6

3.9

1.4

mmol/l

0.28

225

921

(3023183) Ammonium ion [Moles/volume] in Plasma

165

591

2.89

33.74

2.2

3.1

29.2

36.9

umol/l

2.99

135

512

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

213

4.22

33.02

1.2

—

3.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

450

2512

1.92

32.55

10.2

8.7

124.6

123.1

g/l

0.78

441

2417

(3015377) Calcium [Moles/volume] in Serum or Plasma

1193

8702

1.58

32.50

3.2

3.4

2.4

2.3

mmol/l

0.51

960

7703

(3003181) Sodium [Moles/volume] in Urine

130

416

3.21

32.34

1.6

1.3

53.8

65.5

mmol/l

2.30

340

(4198724)

107

5.69

32.22

2.6

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1432

10904

1.55

32.17

2.6

2.2

69.3

76.4

nmol/l

17.40

1241

9935

(3043409) Potassium [Moles/volume] in Arterial blood

197

795

2.57

31.96

9.4

4.1

3.9

mmol/l

0.41

190

751

(3023520) Reticulocytes [#/volume] in Blood

389

2082

1.98

31.81

2.7

74.8

71.2

e9/l

1.30

304

1568

(3020682) Albumin/Creatinine [Ratio] in Urine

1150

8356

1.58

31.65

4.4

4.0

14.5

8.6

mg/mmol

2.89

745

5379

(3037467) Urinalysis macro (dipstick) panel - Urine

2212

18587

1.58

31.55

5.6

4.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

482

2792

1.85

30.99

2.1

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

12.03

30.76

1.7

1.3

40.5

49.2

umol/l

0.50

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

349

1818

2.03

30.76

1.8

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

461

2646

1.86

30.48

2.9

4.2

9.0

29.8

ug/l

2.60

413

2139

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

884

6101

1.61

29.92

1.9

1.8

1.1

mg/l

0.03

681

4664

(3012516) Albumin [Mass/volume] in Urine

1097

7972

1.56

29.73

3.8

3.3

145.9

311.1

mg/l

1.49

707

5113

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

259

1227

2.21

29.23

6.1

3.9

24.3

24.2

mmol/l

0.05

212

1105

(3026008) Bacteria identified in Urine by Culture

1006

7211

1.57

28.76

3.2

2.9

—

(3027944) Amphetamines [Presence] in Urine

219

975

2.33

28.66

5.8

2.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

148

548

2.78

28.46

1.6

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

302

1534

2.07

28.45

4.5

3.1

130.0

130.3

g/l

0.08

294

1492

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3019

27758

2.02

28.27

23.8

13.4

24.5

23.3

mg/l

1.13

2722

21784

(3022948) Iron [Moles/volume] in Serum or Plasma

637

4104

1.68

28.06

2.9

2.5

12.7

13.7

umol/l

2.43

593

3829

(3017143) Hepatitis C virus Ab [Presence] in Serum

532

3266

1.75

27.94

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

168

673

2.58

27.66

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

123

418

3.02

27.65

2.3

3.6

1.1

1.4

0.51

336

(3027945) Reticulocytes/100 erythrocytes in Blood

467

2778

1.79

27.29

2.6

2.0

1.8

3.01

409

2479

(21494755) Public health laboratory ask at order entry panel

116

3022

0.36

27.25

1.3

1.4

—

(40761535) Cells panel - Urine sediment

385

2161

1.88

27.13

3.6

3.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

591

3773

1.69

26.83

3.0

2.5

2.4

2.3

g/l

0.30

543

3524

(3008152) Bicarbonate [Moles/volume] in Arterial blood

313

1645

2.00

26.80

13.6

7.2

25.6

24.5

mmol/l

4.13

300

1527

(3023419) Bacteria identified in Sputum by Culture

107

344

3.18

26.44

2.2

2.6

—

(4146454)

279

3.44

26.41

2.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

121

4.86

26.21

2.2

1.5

257066.0

1478625.0

iu/ml

—

(3037522) Nuclear Ab [Titer] in Serum

596

3844

1.67

25.95

1.4

1.3

354.9

530.4

titre

4.09

126

780

(44816559) Phosphatidylethanol [Mass/volume] in Blood

144

552

2.68

25.90

1.5

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

641

4224

1.64

25.63

1.9

1.6

—

(3000494) Fungus identified in Specimen by Culture

525

3348

1.68

23.68

1.7

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

104

4.97

23.68

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

104

4.97

23.68

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

203

954

2.20

23.32

2.6

2.2

5935.5

5235.2

u/l

0.12

373

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

241

3.42

22.71

1.5

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

241

3.42

22.71

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

241

3.42

22.71

1.5

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

767

5425

1.54

22.30

1.6

1.7

430.1

34717490.9

pmol/l

4.76

620

4577

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

540

3527

1.63

22.06

3.2

2.6

21.8

23.8

2.34

472

3034

(46235355) HIV 1 and 2 tests - Meaningful Use set

725

5077

1.55

22.02

2.1

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

230

1163

2.05

21.85

1.2

1.6

7.7

19.5

u/ml

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2388

21076

1.48

21.54

4.6

3.9

15.0

14.7

pmol/l

5.82

2112

19359

(4035726)

392

2373

1.74

21.29

1.3

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

7.01

21.20

1.7

2.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

131

4.25

21.15

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

133

544

2.51

20.99

3.5

2.8

7.9

8.1

kpa

1.01

123

497

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

128

4.27

20.90

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

108

4.59

20.77

3.1

2.2

146.9

154.1

nmol/l

0.18

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

109

406

2.74

20.77

1.1

1.5

g/l

0.25

364

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

322

1854

1.82

20.73

5.2

4.0

101.7

89.4

ng/l

1.06

282

1632

(3009542) Hematocrit [Volume Fraction] of Blood

2340

25797

0.68

20.63

21.8

14.2

39.6

40.3

2.33

1418

19305

(3000492) Spirometry study

445

2812

1.67

20.60

1.6

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3043

28501

1.86

20.36

26.3

15.0

139.0

139.7

mmol/l

33.90

2972

27825

(3033658) Prothrombin time (PT) actual/Normal

933

6984

1.47

20.29

4.8

4.0

93.2

91.2

1.56

909

6814

(3044889) 12 lead EKG panel

1674

19470

0.72

19.29

4.0

3.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

595

4097

1.55

19.20

2.3

2.1

30.1

29.8

0.35

576

3980

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

470

3072

1.62

18.94

2.7

2.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3044

28599

1.82

18.94

26.0

15.1

4.0

mmol/l

14.91

2965

27879

(3037121) Protein [Mass/volume] in Urine

184

905

2.09

18.82

4.1

3.1

0.4

0.3

g/l

0.61

383

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

761

2.19

18.64

1.4

277.7

286.2

ug/g

0.20

444

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

118

4.20

18.60

1.0

1.1

9.2

7.0

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

430

2761

1.64

18.60

2.7

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

215

1125

1.97

18.54

1.7

1.8

1.7

1.5

g/l

2.21

192

968

(3007463) Buprenorphine [Presence] in Urine

16.07

18.51

7.0

3.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

141

3.88

18.39

1.6

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

141

3.88

18.39

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

141

3.88

18.39

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

141

3.88

18.39

1.6

2.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

288

1664

1.80

18.28

1.7

1.8

1.3

1.4

g/l

0.37

263

1528

(3005322) IgE [Units/volume] in Serum or Plasma

305

1794

1.77

18.22

1.4

1.3

393.1

214.3

u/ml

1.55

289

1654

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.74

18.04

1.5

1.4

0.4

ug/l

0.09

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.71

17.97

3.0

3.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.35

17.77

1.3

1.1

419.9

302.1

pmol/l

0.28

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2754

25318

1.53

17.74

5.8

4.6

1.8

2.1

mu/l

2.39

2474

23376

(3008295) Osmolality of Serum or Plasma

281

2.93

17.65

1.3

1.4

276.6

281.0

mosm/kgh2o

0.83

222

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

177

883

2.06

17.44

2.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

4.15

17.23

1.7

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

4.15

17.23

1.7

2.3

—

(3014271) Vancomycin [Susceptibility]

100

4.34

17.09

3.2

2.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

128

566

2.31

17.05

2.2

2.3

134.4

130.4

g/l

0.79

410

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

12.20

16.92

1.1

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

114

4.08

16.84

3.4

2.9

141.4

169.5

umol/l

0.23

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

4.08

16.84

1.7

2.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

143

3.68

16.48

2.1

2.3

12.6

28.5

umol/l

—

(3021901) Oxygen saturation in Capillary blood

108

452

2.44

16.29

3.4

2.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

117

3.97

16.27

1.2

1.9

19.5

88.4

ug/l

0.51

103

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

139

656

2.17

15.84

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

722

5357

1.45

15.82

1.6

1.5

2.5

2.4

g/l

0.06

410

3375

(3005719) IgG [Mass/volume] in Serum or Plasma

341

2149

1.65

15.78

2.7

9.8

10.5

g/l

3.07

310

1967

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

128

588

2.22

15.60

1.3

1.2

3.9

u/ml

—

(3004588) Protein electrophoresis panel - Serum or Plasma

286

1729

1.72

15.47

1.7

2.5

—

(40758558) Short blood count panel - Blood

903

7022

1.39

15.06

7.9

6.7

—

(3017181) Myelocytes/100 leukocytes in Blood

360

2328

1.61

15.00

3.6

4.3

0.9

0.13

161

645

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

134

640

2.14

14.83

1.7

1.8

—

(3045424) Erythrocytes [Presence] in Urine

111

492

2.30

14.74

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

147

732

2.06

14.59

1.4

1.2

5.0

2.7

u/ml

0.38

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1145

9293

1.36

14.51

3.4

3.3

33.6

35.9

u/l

0.35

1068

8853

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

148

742

2.04

14.42

1.4

1.2

3.0

7.1

u/ml

1.20

118

(1616796) Gas panel - Central venous blood

122

569

2.19

14.35

5.2

3.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

327

2091

1.63

14.25

2.1

2.8

65.7

66.6

g/l

1.21

286

1933

(3002179) Metamyelocytes/100 leukocytes in Blood

331

2139

1.61

13.80

3.5

4.1

0.6

0.02

134

473

(40768797) Stomach Pathology biopsy report

534

3835

1.47

13.69

1.4

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

930

7363

1.37

13.64

2.8

2.6

892.7

4198.8

umol/l

5.37

795

6490

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

509

2.22

13.62

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

110

509

2.20

13.22

1.6

1.3

—

(3049717) Cytology report of Urine Cyto stain

178

980

1.86

13.21

2.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

163

873

1.91

13.16

1.8

1.6

0.2

7.4

iu/ml

0.50

166

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

335

2.48

13.09

1.3

—

nmol/l

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

8.93

12.89

1.5

1.1

86.2

37.5

mg/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

333

2.47

12.77

1.4

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

426

2.29

12.76

1.4

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

336

2219

1.57

12.76

3.7

4.3

0.1

0.89

148

596

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

161

2836

0.55

12.74

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

492

2.19

12.65

1.4

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

468

3330

1.47

12.51

2.5

2.4

162.8

139.6

ug/g

0.43

345

2669

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

161

3.14

12.48

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

182

3.00

12.48

2.7

2.8

578.8

554.6

e6/l

0.12

160

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

177

3.03

12.44

2.7

2.8

0.3

0.2

e9/l

0.29

160

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

115

556

2.11

12.39

1.6

1.5

—

(3010421) pH of Blood

136

708

1.96

11.97

6.6

4.3

7.4

1.31

112

591

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

639

4857

1.39

11.82

1.3

36.8

31.2

iu/ml

0.38

173

1558

(3035637) Corticotropin [Mass/volume] in Plasma

340

2.39

11.76

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

391

2.28

11.69

1.4

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

113

556

2.07

11.64

2.1

3.7

1003.4

795.8

u/ml

0.08

101

515

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

287

2.51

11.63

2.0

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

144

774

1.90

11.54

1.1

1.2

113.3

93.8

titre

0.24

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1891

0.48

11.52

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

382

2.28

11.44

1.2

1.3

0.2

0.4

nmol/l

1.12

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

766

6022

1.35

11.43

1.3

1.2

1.4

1.8

u/ml

0.49

166

1655

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

308

2.43

11.40

1.9

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

427

5856

0.69

11.39

2.7

2.9

0.6

0.7

ug/l

2.86

299

3777

(3023511) Choriogonadotropin [Units/volume] in Urine

102

490

2.12

11.20

1.5

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

245

2.60

11.18

3.5

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

125

649

1.96

11.11

1.7

7677.5

12134.6

e6/l

1.19

473

(40768804) Tissue Pathology biopsy report

1315

11194

1.29

11.01

2.2

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

474

2.12

10.97

1.7

1.9

—

(3022145) Colonoscopy Study observation

432

3109

1.45

10.81

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

109

3.42

10.68

4.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

604

4618

1.38

10.68

1.3

15.7

10.5

u/ml

0.78

201

1885

(3001019) Free T4 and TSH panel - Serum or Plasma

1602

0.46

10.66

1.4

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

414

2.18

10.62

1.4

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

4.25

10.55

1.3

1.4

48.4

66.5

mu/l

0.34

(3018418) pH of Serum or Plasma

939

7683

1.31

10.49

5.2

4.2

7.4

0.02

181

1505

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

108

3.36

10.12

3.0

2.4

—

(3052851) Hemolysis interference index of Serum or Plasma

142

797

1.82

9.97

4.2

3.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

140

785

1.82

9.86

1.8

—

(3012501) Base excess in Blood by calculation

114

599

1.94

9.82

6.4

4.5

2.9

2.4

mmol/l

0.94

415

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

3.06

9.65

1.1

86.8

83.1

u/l

0.13

101

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1360

11763

1.27

9.60

3.2

2.8

127.2

129.8

ug/l

0.19

1216

10990

(3016038) Potassium [Moles/volume] in Urine

149

2.91

9.54

1.4

1.1

28.6

36.5

mmol/l

1.97

136

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

133

3.03

9.53

1.1

25.1

23.3

u/l

0.08

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.46

9.46

1.2

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

429

3158

1.41

9.43

2.3

2.8

8.4

7.9

umol/l

0.12

335

2775

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.60

9.35

5.2

5.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

143

826

1.76

9.15

2.8

3.4

0.4

0.3

u/ml

1.13

461

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.02

9.09

1.1

1.0

—

(3025159) Blasts/100 leukocytes in Blood

302

2096

1.49

9.08

3.8

4.3

0.0

0.4

0.89

137

501

(3026782) Osmolality of Urine

646

5105

1.33

9.07

3.2

2.7

473.5

554.4

mosm/kgh2o

18.36

577

4339

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

224

2.48

8.95

1.1

1.2

—

(3019977) pH of Arterial blood

133

2.96

8.92

2.8

7.4

0.18

(3034770) Mitochondria Ab [Titer] in Serum

135

773

1.78

8.90

1.2

942.9

1147.5

titre

—

(3000093) Morphology [Interpretation] in Blood Narrative

237

2.43

8.88

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

641

7970

0.76

8.88

3.3

4.0

20.5

21.5

0.86

295

3713

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

5.17

8.88

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

5.74

8.80

2.9

1.2

—

(40768446) Kidney Pathology biopsy report

114

3.09

8.66

1.8

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

355

2.14

8.64

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

871

1.72

8.62

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

247

2.37

8.59

4.6

4.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.89

8.41

2.1

2.0

12.8

17.1

umol/l

1.33

(40768443) Skin Pathology biopsy report

181

1143

1.62

8.33

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

258

2.31

8.24

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2700

25546

1.31

8.11

7.1

5.5

41.4

39.5

mmol/mol

9.25

2407

23872

(3000850) Epithelial cells [#/volume] in Urine

684

5528

1.30

8.07

2.9

2.6

7.6

5.5

e6/l

2.93

615

4834

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

121

692

1.78

8.05

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

307

2190

1.44

8.01

2.5

2.3

6.8

8.1

ug/l

0.47

251

1974

(40767503) Oxygen content in Capillary blood by calculation

102

555

1.86

7.97

3.2

2.5

16.7

16.5

0.14

274

(3015736) pH of Urine

1178

10178

1.24

7.96

3.7

3.2

—

5.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

201

2.46

7.90

2.7

2.6

852.0

699.6

e6/l

0.80

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

376

2.05

7.83

1.3

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

445

1.96

7.82

1.3

1.6

0.5

0.8

g/l

2.74

332

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

188

1219

1.57

7.76

1.5

1.9

42.0

39.1

u/l

1.05

154

1089

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

274

2.21

7.60

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

5.19

7.44

1.3

1.2

—

(3001556) Androgen free Index in Serum or Plasma

5.19

7.44

1.6

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

238

2.29

7.44

1.2

1.4

—

(3011412) CD3 cells [#/volume] in Blood

270

2.21

7.44

2.7

2.6

1.4

1.1

e9/l

0.45

167

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

504

1.87

7.39

1.8

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

143

2.68

7.31

1.3

44.0

56.7

titre

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

185

2.45

7.24

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.30

7.21

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

186

2.44

7.17

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

251

2.21

7.00

1.3

1.5

28612.4

80156.9

e6/l

1.25

149

(3011985) Renin [Units/volume] in Plasma

366

1.99

6.93

1.2

1.4

201.5

57.3

mu/l

0.97

335

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.86

6.93

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

285

2.13

6.92

1.3

1.5

8236.1

2381.1

e6/l

0.65

203

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2771

26439

1.30

6.90

18.7

12.3

86.7

83.5

ml/min/173m2

11.01

2488

21845

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

487

1.85

6.89

1.1

—

(36660697) Celiac disease serology panel - Serum

292

2122

1.41

6.89

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

742

6173

1.26

6.81

3.8

3.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

100

572

1.77

6.71

1.6

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

270

2.13

6.64

1.2

52.0

56.0

u/l

0.27

192

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

183

2.37

6.46

1.9

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

165

2.44

6.43

1.3

1.5

10.8

13.0

u/l

1.66

158

(3021879) Hepatitis B virus core Ab [Presence] in Serum

292

2149

1.39

6.41

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

703

0.38

6.37

1.1

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

197

2.30

6.35

1.0

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

564

4578

1.28

6.31

2.7

3.1

2.5

2.4

mmol/l

3.56

503

4027

(3017569) Oxygen content in Arterial blood

131

2.61

6.29

3.2

2.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

120

736

1.65

6.28

1.4

—

(3028433) Virus identified in Specimen by Culture

2.95

6.26

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

180

2.35

6.22

1.9

1.2

—

(4062490)

284

2.06

6.22

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

129

809

1.62

6.18

1.4

1.3

11.1

9.8

u/l

0.47

656

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

375

1.91

6.16

6.2

6.8

11.5

mg/l

0.00

352

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

191

2727

0.68

6.14

1.3

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

839

7148

1.23

6.14

4.1

3.8

0.0

estimate

1.70

247

2492

(3010144) Erythrocytes [#/volume] in Synovial fluid

266

2.09

6.10

1.5

1.4

57210.2

80499.2

e6/l

0.17

184

(3003434) Protein [Mass/volume] in Pleural fluid

307

2.01

6.08

1.3

1.5

36.4

33.1

g/l

1.26

275

(3024928) Oxygen saturation in Venous blood

562

1.73

5.98

4.7

2.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

282

2.04

5.96

1.3

1.4

6.8

6.6

g/l

0.12

192

(3028192) IgG subclass 2 [Mass/volume] in Serum

282

2.04

5.96

1.3

1.4

2.3

3.0

g/l

2.69

191

(3030467) Casts [#/volume] in Urine by Automated count

859

7362

1.23

5.90

3.8

3.0

0.6

0.4

e6/l

1.27

665

5507

(3019150) Specific gravity of Urine by Refractometry

683

5712

1.25

5.90

4.4

3.8

1.0

kg/l

0.64

103

809

(3034274) Bile acid [Moles/volume] in Serum --fasting

304

1.99

5.89

1.6

2.1

11.7

5.3

umol/l

0.39

215

(3027456) Digoxin [Moles/volume] in Serum or Plasma

383

1.87

5.80

3.5

3.1

0.9

0.8

nmol/l

0.23

299

(3027923) C peptide [Moles/volume] in Serum or Plasma

161

2.38

5.80

1.4

1.2

nmol/l

0.21

127

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

356

1.90

5.74

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.47

5.72

3.5

3.0

—

(40761511) CBC panel - Blood by Automated count

3003

29103

1.35

5.72

22.9

12.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

129

826

1.58

5.70

1.9

1.6

0.2

g/l

0.25

124

784

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2809

26983

1.27

5.70

5.5

4.4

6.2

5.9

mmol/l

20.47

2484

24866

(3024139) IgG subclass 3 [Mass/volume] in Serum

282

2.00

5.60

1.3

1.4

0.4

g/l

0.12

191

(3047352) Trisomy 18 risk [Likelihood] in Fetus

524

0.34

5.44

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.24

5.44

1.2

1.3

271.1

60.9

ug/l

0.64

(3037756) Immunofixation for Serum or Plasma

510

1.72

5.43

1.5

1.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

132

862

1.55

5.38

1.8

1.6

1.2

g/l

0.02

125

817

(3016650) Hepatitis A virus Ab [Presence] in Serum

474

1.75

5.38

1.1

—

(3042733) HLA Ab [Presence] in Serum

101

2.69

5.33

7.3

4.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

737

6292

1.22

5.18

5.5

4.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

349

1.85

5.10

1.2

1.4

432.6

288.2

pmol/l

1.38

278

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

178

2.21

5.06

2.4

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

328

2551

1.32

5.05

1.8

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

128

2.44

5.04

1.2

1.1

1515.1

1534.6

miu/ml

0.03

128

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.90

4.98

1.1

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

240

2.01

4.94

1.0

1.1

289.3

284.9

mg/l

0.16

221

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

180

2.18

4.93

1.3

1.1

1.0

ratio

0.71

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

243

1815

1.37

4.91

1.3

20.2

50.7

au/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

997

0.54

4.90

2.0

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

169

2.20

4.81

1.4

13.1

20.2

u/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

535

0.39

4.80

1.6

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

131

878

1.51

4.78

1.9

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.58

4.76

12.4

9.5

4.6

6.5

mmol/l

1.63

(3019174) dRVVT (LA screen)

3.95

4.71

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3047

29696

1.34

4.70

25.5

15.4

77.1

76.8

umol/l

0.16

3047

29687

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

603

5099

1.22

4.61

4.3

3.5

478.2

649.1

ng/l

0.34

457

3797

(3000330) Specific gravity of Urine by Test strip

1239

0.60

4.58

4.3

3.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

590

1.61

4.58

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

590

1.61

4.58

1.6

1.4

—

17.0

—

(3005033) Fetal Nuchal fold Thickness US

521

0.40

4.54

1.5

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.83

4.53

1.0

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

536

4490

1.23

4.49

3.3

2.6

1.3

1.0

e6/l

1.08

321

2537

(3034860) Kappa light chains.free [Mass/volume] in Serum

115

761

1.53

4.47

2.3

3.9

45.3

62.5

mg/l

0.88

611

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

168

2.16

4.46

1.5

1.6

8.7

7.1

u/l

0.11

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

113

746

1.53

4.45

2.3

3.8

4.0

2.3

ratio

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

115

763

1.53

4.42

2.3

3.9

38.1

69.1

mg/l

0.92

615

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

198

1458

1.38

4.40

10.6

10.8

—

(3012441) Differential panel - Pleural fluid

245

1.93

4.34

1.3

1.5

—

(36304419) Bacteria [Presence] in Urine

824

7215

1.19

4.34

3.8

3.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

177

2.10

4.32

1.4

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

211

2.00

4.31

1.6

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.79

4.28

3.1

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.79

4.28

3.0

2.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

258

1990

1.32

4.24

2.5

2.4

27.1

23.1

au/ml

—

119

(3041096) Erythrocytes [Presence] in Urine by Automated

629

7289

0.83

4.18

3.6

3.1

—

(40768800) Prostate Pathology biopsy report

611

0.47

4.16

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

249

1.90

4.16

1.4

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

2.44

4.13

3.1

2.0

249.7

27933.2

u/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

1085

1.42

4.07

1.4

1.2

0.5

1.1

u/ml

0.74

(40768441) Liver Pathology biopsy report

203

1.98

4.01

1.3

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

117

2.32

4.01

1.1

1.3

4.3

4.7

umol/l

0.21

110

(3021788) Differential panel - Synovial fluid

486

1.62

3.97

1.8

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

112

758

1.49

3.96

1.7

1.9

12.6

11.1

mg/l

0.84

102

703

(4094501)

820

0.55

3.94

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

269

1.83

3.91

2.4

5.7

7.7

7.2

mmol/l

0.42

227

(40760888) Immunoglobulin light chains.free panel - Serum

575

1.56

3.90

2.2

4.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.18

3.88

6.9

7.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

158

2.10

3.87

1.2

1.3

12.5

12.3

u/l

0.03

147

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

113

771

1.48

3.85

1.8

2.4

37.2

37.9

g/l

0.57

682

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.78

3.85

1.0

—

(3006462) Nitrate [Presence] in Urine

113

2.31

3.84

4.6

3.4

—

(3002582) Erythrocytes [#/volume] in Urine

904

8050

1.17

3.82

3.9

3.1

74.9

98.2

e6/l

0.43

739

6152

(3044290) Cell count panel - Cerebral spinal fluid

587

1.55

3.79

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

133

2.19

3.79

3.1

2.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3044

29763

1.29

3.77

15.1

10.2

27.3

27.5

u/l

0.17

2942

28832

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

283

2248

1.28

3.76

4.2

2.5

73.1

69.0

ml/min/173m2

0.94

130

841

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

127

2.22

3.76

2.9

2.5

63.2

52.7

umol/l

0.86

106

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

244

1.86

3.74

2.0

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

590

1.54

3.71

6.0

741.3

511.0

iu/ml

0.17

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

567

1.55

3.69

3.7

3.8

59.9

57.2

1.28

567

(4024509)

240

1.84

3.61

1.9

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

428

1.63

3.60

2.7

2.0

1.5

1.7

mmol/l

0.85

419

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

314

1.73

3.59

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

575

0.50

3.54

6.1

4.1

—

(4211845)

124

2.19

3.54

4.7

3.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

471

1.58

3.49

1.1

3.0

1175.6

iu/ml

0.55

114

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

332

1.70

3.48

1.5

1.7

45.0

59.1

1.46

203

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.56

3.48

2.3

2.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.42

3.47

2.7

2.8

25.5

29.7

umol/l

—

(3020491) Glucose [Moles/volume] in Blood

201

1.90

3.43

3.2

1.6

6.8

mmol/l

0.01

133

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

318

2594

1.25

3.41

3.3

2.4

42.5

56.3

u/l

0.32

267

2251

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.99

3.41

1.0

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.35

3.40

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

202

1.89

3.39

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

217

1690

1.30

3.38

3.3

3.4

4.5

pmol/l

0.04

192

1514

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

645

1.49

3.36

2.1

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

566

1.52

3.30

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

560

1.51

3.25

1.3

1.2

312.1

268.6

u/ml

0.53

357

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.34

3.24

2.0

1.3

13.6

15.4

pmol/l

0.64

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

531

1.52

3.17

1.8

1.4

101.6

118.6

u/ml

0.67

101

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.96

3.13

1.5

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.25

3.12

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

664

1.46

3.12

2.1

2.4

236.3

126.0

ug/min

0.72

415

(3025315) Body weight

4.51

3.11

6.7

2.8

—

(3045414) Leukocytes [Presence] in Urine

164

1245

1.33

3.09

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

268

1.73

3.08

3.7

3.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

329

1.65

3.07

2.2

2.4

—

(3051593) INR in Capillary blood by Coagulation assay

2.23

3.05

1.2

12.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.46

3.04

2.5

2.3

—

(3002256) Pathology report gross observation

421

3582

1.20

3.01

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

10.01

2.98

1.2

233.1

635.4

nmol/l

—

(1002224) Polysomnography panel

1301

0.70

2.93

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

121

2.07

2.92

2.4

2.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.32

2.91

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

108

2.14

2.90

1.3

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

585

1.46

2.86

1.7

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

952

0.66

2.84

1.6

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

141

1062

1.34

2.83

1.4

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.77

2.81

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.77

2.81

1.0

1.1

99.0

99.2

0.01

(44806071)

3.06

2.80

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

116

849

1.38

2.79

1.9

2.6

0.8

0.9

g/l

0.12

753

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.34

2.75

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

293

1.65

2.75

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

152

1.92

2.75

1.4

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

2.10

2.68

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

272

1.66

2.68

1.8

2.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

166

1292

1.30

2.66

3.2

45.9

49.3

u/ml

0.09

161

1247

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

202

0.35

2.64

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

168

1313

1.29

2.62

2.7

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.47

2.61

1.7

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

206

1.76

2.61

1.4

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

393

1.54

2.59

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

185

1.79

2.56

1.9

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

245

2009

1.24

2.56

2.9

2.8

314.4

171.9

ng/l

0.83

218

1815

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.13

2.54

1.6

2.0

6.4

9.6

mg/l

2.14

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

670

1.40

2.49

1.9

2.0

5.1

4.9

iu/l

0.06

239

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1909

18203

1.12

2.49

3.3

3.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

374

1.53

2.45

1.6

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

122

922

1.34

2.43

1.8

2.5

3.3

3.1

g/l

1.97

740

(3021601) Nitrite [Presence] in Urine by Test strip

1410

13236

1.11

2.43

5.0

4.6

0.0

estimate

0.80

267

2585

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

153

1.84

2.38

1.4

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1423

13377

1.11

2.37

3.9

3.4

0.0

estimate

1.34

258

2459

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

426

1.49

2.37

1.4

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.21

2.37

1.2

1.3

36.3

27.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.42

2.36

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

728

1.37

2.36

1.3

559.6

518.5

mg/l

0.23

690

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

451

1.47

2.36

1.3

1.4

—

(44806118)

322

1.56

2.35

1.7

1.5

—

(44790048)

322

1.56

2.35

1.7

1.5

—

(44790047)

322

1.56

2.35

1.7

1.5

—

(44790049)

322

1.56

2.35

1.7

1.5

—

(3018095) Leukocytes [#/volume] in Urine

1020

9421

1.12

2.34

4.6

3.6

79.4

92.8

e6/l

0.30

790

6635

(3035880) pH of Pleural fluid

133

1.89

2.31

1.1

1.4

—

(3044941) Cell count panel - Synovial fluid

437

1.47

2.30

1.7

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.86

2.30

1.2

1.1

—

(4306422)

471

1.45

2.28

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

470

0.57

2.26

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

134

1.87

2.26

2.0

1.9

—

(3024932) HLA-DR beta [Type]

2.03

2.26

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1.74

2.22

1.4

1.6

—

(4038314)

5.56

2.21

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

225

1.65

2.21

1.4

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

729

1.35

2.20

1.1

25.3

5.1

u/ml

—

100

(3022493) Free Hemoglobin [Mass/volume] in Plasma

107

1.97

2.20

1.1

7.0

53.9

62.2

mg/l

0.41

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

373

4283

0.85

2.18

1.7

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

121

932

1.31

2.15

1.3

1.5

—

(3024471) HLA-A [Type]

101

1.99

2.15

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.17

2.14

1.3

1.6

8.6

2.7

0.81

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

212

1.66

2.13

1.4

1.3

2.3

0.6

u/ml

0.57

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

454

1.44

2.11

1.2

85.6

45.1

u/l

0.51

389

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

691

0.66

2.10

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

910

1.31

2.09

1.8

2.5

9.1

10.3

g/l

2.30

792

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.01

2.07

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.11

2.02

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.51

2.01

1.3

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

699

1.34

1.98

1.9

2.5

0.0

g/l

0.00

655

(3045716) Anion gap in Serum or Plasma

126

1.83

1.98

4.2

2.4

10.3

9.6

mmol/l

0.20

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

469

1.42

1.97

1.1

1.2

4.2

5.0

u/ml

0.28

190

(3051651) Icteric interference index of Serum or Plasma

164

1.71

1.94

3.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.75

1.93

1.0

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.12

1.92

1.2

1.5

17.7

27.7

1.06

(4133840)

2.01

1.90

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

470

0.61

1.89

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

749

1.32

1.88

1.9

2.5

0.0

g/l

1.29

703

(3000034) Microalbumin [Mass/volume] in Urine

260

1.55

1.86

3.0

28.1

28.8

mg/l

0.02

197

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

100

1.91

1.85

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

981

1.27

1.84

1.7

2.5

7.7

7.3

g/l

2.11

760

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

981

1.27

1.84

1.7

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

171

1404

1.23

1.84

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.17

1.82

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

111

868

1.29

1.81

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.96

1.79

1.7

2.3

63693.8

22507.5

e6/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.76

1.79

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

694

1.32

1.79

1.9

2.5

0.0

g/l

0.00

654

(3024891) Influenza virus A+B Ag [Presence] in Specimen

721

1.31

1.78

1.4

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

192

1.62

1.77

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.34

1.77

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

152

0.39

1.76

1.7

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

981

1.26

1.73

1.7

2.5

3.9

3.8

g/l

0.25

726

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

469

4210

1.13

1.73

3.7

2.8

2.9

2.2

e6/l

0.81

256

2265

(3002523) Influenza virus A Ag [Presence] in Specimen

470

0.63

1.72

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

725

1.31

1.72

3.3

3.0

1.7

1.5

mg/l

1.48

677

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

125

1.77

1.71

2.6

1.7

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

3.4

0.0

u/ml

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.96

1.69

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

451

1.38

1.67

1.0

1.1

125.7

115.6

2.40

411

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

451

1.38

1.67

3.5

2.8

—

1580.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.16

1.66

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.93

1.64

2.3

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.98

1.64

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

127

1.74

1.64

1.1

1.2

—

(3036489) Thrombin time

132

1071

1.24

1.62

2.2

2.0

20.3

21.4

2.28

107

928

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

549

4996

1.12

1.62

1.6

1.5

—

(3011648) Oxygen content in Venous blood

214

1.55

1.59

3.8

2.1

10.6

11.2

0.49

214

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

1.64

1.58

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

614

1.31

1.54

3.4

2.0

0.9

0.8

nmol/l

0.16

516

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

634

0.71

1.54

1.3

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

184

1.58

1.54

1.2

—

(3048879) Bone marrow aspiration report

1.98

1.53

1.1

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

365

1.40

1.53

1.1

—

(3008898) HLA-B27 [Presence]

126

1025

1.24

1.53

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.86

1.50

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.86

1.50

1.8

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

101

1.79

1.48

1.8

2.6

505.2

765.3

e6/l

0.68

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1383

13217

1.08

1.40

3.8

3.4

0.0

estimate

0.80

257

2500

(3033705) Calcium.ionized [Moles/volume] in Venous blood

276

0.58

1.40

2.5

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.90

1.39

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

207

1.50

1.35

1.9

2.2

10.5

14.6

1.72

(3003694) ABO and Rh group [Type] in Blood

846

7939

1.09

1.34

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.92

1.33

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.30

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.36

1.29

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

561

1.29

1.6

—

(40768793) Breast Pathology biopsy report

553

1.29

1.28

1.4

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.00

1.27

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

236

1.45

1.24

2.6

2.1

35.7

45.6

1.26

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

123

1.63

1.24

2.1

3.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

637

0.75

1.19

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

636

0.75

1.18

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

173

1.51

1.17

1.3

1.5

6.1

7.5

u/l

0.63

150

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.78

1.16

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.78

1.16

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

299

1.38

1.16

1.9

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.05

1.15

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.05

1.15

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.05

1.15

1.0

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.05

1.15

2.9

1.9

1.2

mmol/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.50

1.15

8.6

5.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

118

1.61

1.14

1.2

1.0

—

(3017704) Immunofixation for Urine

150

1.54

1.14

1.6

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

853

1.21

1.12

1.3

215.3

213.8

miu/ml

0.01

397

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.12

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

119

1.60

1.11

2.2

2.1

—

(3041354) Potassium [Moles/volume] in Venous blood

281

0.64

1.10

2.4

2.7

4.2

4.1

mmol/l

0.42

276

(3035285) Chloride [Moles/volume] in Venous blood

281

0.64

1.10

2.4

2.7

106.4

105.5

mmol/l

0.53

276

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

477

1.28

1.10

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.38

1.09

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

648

1.24

1.08

1.2

1.3

4.0

3.8

mmol/l

1.05

611

(44813793)

185

1.46

1.08

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

615

0.76

1.08

2.7

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

101

840

1.21

1.07

2.8

2.5

3.7

3.6

g/l

0.16

792

(3025941) Bacteria identified in Stool by Culture

179

1565

1.15

1.05

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

635

0.77

1.05

1.3

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

1.05

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

271

1.37

1.04

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

508

1.26

1.04

2.0

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2727

27649

0.92

1.02

5.1

4.3

1.3

1.5

mmol/l

39.12

2437

25798

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.89

1.01

1.0

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

1.62

0.99

1.5

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.67

0.97

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.95

0.97

1.0

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

165

1.46

0.96

1.2

1.3

147.7

136.5

nmol/l

0.57

165

(3029396) Erythrocyte agglutination [Presence] in Blood

1.80

0.96

2.9

3.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

351

3218

1.10

0.96

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.95

0.0

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.69

0.95

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

225

1.38

0.94

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

107

912

1.18

0.90

2.6

2.1

95.8

91.4

1.45

855

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.75

0.90

1.1

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.07

0.89

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

211

1891

1.12

0.89

1.2

145.8

143.8

iu/ml

0.02

713

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

786

7472

1.07

0.89

1.7

1.4

mmol/l

6.97

693

6300

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

242

0.66

0.88

2.1

1.5

0.9

1.0

g/l

0.16

242

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

951

9929

0.94

0.87

4.0

4.6

1.9

2.6

ug/l

2.46

804

8984

(40765096) Chromosome analysis panel by Banding

1.61

0.87

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.86

0.87

5.6

4.6

—

(3047189) Immunofixation for 24 hour Urine

136

1.47

0.86

1.3

1.7

—

(4268621)

317

1.30

0.85

1.8

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

274

0.69

0.84

1.3

1.2

—

(3004451) EKG impression Narrative

138

1.45

0.81

1.2

1.3

—

(3047181) Lactate [Moles/volume] in Blood

100

857

1.17

0.81

7.0

6.6

1.2

1.3

mmol/l

1.08

743

(3045683) HLA typing for celiac disease panel - Blood or Tissue

164

1.41

0.79

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

465

1.23

0.78

1.6

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

123

0.57

0.77

1.6

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

148

1.42

0.77

1.2

—

(3036603) Volume of Urine

184

1.36

0.73

1.3

1.5

1607.0

2039.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.80

0.72

1.3

1.2

—

(3034426) Prothrombin time (PT)

109

0.55

0.72

1.0

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

309

0.74

0.70

1.2

1.4

18.5

4.1

ug/l

0.42

275

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

1.38

0.69

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.53

0.69

1.2

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

341

0.76

0.68

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

119

0.59

0.67

1.0

1.2

—

0.1

g/l

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

240

1.29

0.67

1.1

1.2

32.3

42.0

mg/l

1.18

198

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

233

2141

1.09

0.66

4.1

4.0

1.2

mmol/l

0.68

210

1878

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

232

1.30

0.66

1.1

291.9

283.1

mg/l

0.09

201

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

128

1.41

0.65

1.2

1.1

370.0

188.0

iu/ml

0.46

128

(3013637) Mi-2 Ab [Presence] in Serum

1.57

0.65

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.57

0.65

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.57

0.65

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.57

0.65

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.73

0.64

1.8

2.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

155

1.36

0.63

1.3

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

447

0.80

0.62

1.6

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

113

1.42

0.61

1.1

3227.2

243.2

ng/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

797

1.15

0.61

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

1.43

0.60

1.1

1.2

—

(3024263) Appearance of Synovial fluid

148

1.35

0.59

1.5

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

3.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

149

1349

1.11

0.59

3.3

2.8

0.6

0.3

e6/l

0.63

143

1312

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.51

0.58

1.0

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

474

1.18

0.58

3.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

173

0.69

0.57

6.4

6.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

794

1.14

0.55

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.54

0.55

1.1

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

805

1.13

0.54

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

425

0.82

0.52

1.2

1.4

0.3

nmol/l

0.59

323

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.43

0.52

1.0

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.50

0.51

1.5

99.3

131.0

ng/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

630

1.15

0.51

1.4

36.5

26.2

e6/l

0.15

488

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

631

1.14

0.50

1.4

2794.9

1410.3

e6/l

0.24

514

(3013139) Helicobacter pylori Ag [Presence] in Stool

197

1827

1.08

0.49

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.56

0.49

1.9

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

1.37

0.48

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.40

0.48

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

143

1319

1.09

0.43

1.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.56

0.42

1.4

1.8

16.2

7.1

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

30.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2805

28237

0.96

0.40

5.4

4.8

2.6

2.8

mmol/l

15.62

2506

26335

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

30.2

—

(3044007) Cell count panel - Peritoneal fluid

1.39

0.40

1.1

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

540

0.87

0.40

1.1

1.2

1.5

u/ml

0.16

218

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2762

27812

0.96

0.40

4.9

4.4

4.5

4.7

mmol/l

16.24

2477

26070

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.31

0.39

10.4

7.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.39

0.0

2.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

215

0.79

0.39

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.36

0.38

1.0

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.36

0.38

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.39

0.38

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

251

2379

1.06

0.38

2.5

2.2

11.9

13.1

nmol/l

1.10

190

2119

(40761536) Microorganisms panel - Urine sediment

248

2350

1.06

0.37

4.4

3.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

477

1.13

0.37

1.2

5.1

4.4

u/ml

0.07

152

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.31

0.37

10.1

7.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

114

1051

1.09

0.36

6.1

5.7

2.7

1.7

5.47

107

979

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.64

0.35

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

153

1.24

0.35

1.4

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

292

1.17

0.34

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

189

0.79

0.34

2.6

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

424

1.13

0.34

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

136

1.25

0.33

21.9

26.0

136.5

118.3

ug/l

—

111

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.70

0.33

1.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

290

2777

1.05

0.32

4.4

3.2

—

(3004775) Volume in Urine collected for unspecified duration

220

1.18

0.31

2.1

2.2

569.9

634.6

0.29

151

(3004716) Salmonella sp identified in Stool by Organism specific culture

132

1409

0.93

0.31

1.2

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2657

26738

0.97

0.31

4.5

3.9

1.5

1.3

mmol/l

28.59

2368

24813

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

147

1.23

0.30

1.7

2.0

3.1

u/field

0.43

109

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

951

0.92

0.29

2.8

3.6

392.5

2567.1

u/ml

1.00

814

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.23

0.29

1.1

1.3

—

145.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.32

0.28

1.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

780

0.92

0.26

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.26

1.5

9.6

8.8

ug/l

0.22

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

477

0.90

0.25

1.1

—

(3025130) Human papilloma virus identified in Specimen

361

0.89

0.24

1.9

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

287

0.87

0.24

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

133

1.20

0.24

1.4

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

176

1681

1.05

0.24

2.0

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

227

1.15

0.23

1.8

1.9

20.1

18.8

nmol/l

0.26

211

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.23

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

143

1.19

0.23

2.2

2.4

593.0

1126.4

u/ml

1.53

143

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.25

0.22

1.2

1.1

105.7

89.8

—

(21494434) Karyotype in Bone marrow

238

1.14

0.22

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

126

1197

1.05

0.21

1.4

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.19

0.21

1.2

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.16

0.21

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

230

0.87

0.21

1.2

1.4

12.8

12.3

mmol/l

0.12

(3016750) Collection duration of Urine

173

1.16

0.21

1.6

2.1

520.3

487.1

min

0.63

129

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

376

0.90

0.20

1.1

17.3

3.6

u/ml

0.84

139

(3023410) Appearance of Cerebral spinal fluid

278

1.12

0.20

1.8

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

136

1.18

0.20

1.8

2.1

53.5

178.7

ug/min

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

438

0.91

0.20

1.1

6.6

2.0

u/ml

—

106

(4281824)

271

0.88

0.20

1.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.18

0.19

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

588

1.07

0.19

1.3

1.2

13.5

43.0

u/ml

—

(3015183) Erythrocyte sedimentation rate

153

0.85

0.18

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

110

1.18

0.17

1.1

1.0

—

(3025577) Chromium [Mass/volume] in Blood

167

1.14

0.16

2.1

2.0

1.7

2.2

ug/l

0.69

146

(3045142) Bone marrow Pathology biopsy report

309

0.91

0.16

1.5

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.20

0.16

1.2

2.2

234.2

167.3

0.77

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

256

0.90

0.16

1.2

1.4

44.3

170.3

pmol/l

0.60

(3051387) C reactive protein [Mass/volume] in Capillary blood

535

1.07

0.16

5.9

3.6

18.6

25.4

mg/l

1.11

331

(3020650) Glucose [Presence] in Urine

0.79

0.14

1.7

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.82

0.13

2.4

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.82

0.13

2.6

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

201

0.89

0.13

2.2

2.1

0.7

1.8

u/field

1.57

(3035320) C reactive protein [Mass/volume] in Body fluid

180

0.89

0.13

4.2

2.2

—

(3021589) Normoblasts [#/volume] in Blood

1238

12280

1.01

0.13

12.1

9.4

0.0

e9/l

0.19

1048

10083

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.18

0.12

1.2

1.3

120.6

88.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

426

0.94

0.12

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

313

0.93

0.12

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

133

1.13

0.12

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

124

1.13

0.11

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

124

1.13

0.11

1.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

124

1.13

0.11

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

109

1126

0.97

0.11

1.6

1.7

6.2

3.9

mg/l

1.04

793

(3023430) Cat dander IgE Ab [Units/volume] in Serum

342

0.94

0.10

1.1

7.9

4.5

u/ml

0.29

132

(3007930) Methemoglobin/Hemoglobin.total in Blood

101

1044

0.97

0.10

6.4

5.7

0.8

0.9

1.68

974

(3000963) Hemoglobin [Mass/volume] in Blood

3108

31123

0.98

0.10

34.9

19.7

134.8

137.0

g/l

11.92

3072

30748

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

961

0.97

0.10

1.9

1.8

43.1

39.7

nmol/l

0.56

926

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

693

1.04

0.09

1.9

181.9

202.5

pmol/l

0.92

656

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

145

1.10

0.09

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

155

0.90

0.09

1.1

—

(3010813) Leukocytes [#/volume] in Blood

3108

31118

0.98

0.09

34.8

19.7

8.1

6.7

e9/l

162.98

3065

30329

(40757373) Influenza virus identified in Isolate

1.07

0.08

2.3

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.77

0.08

1.0

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

3108

31113

0.98

0.07

34.7

19.6

4.4

4.5

e12/l

24.41

3061

30333

(3029075) Extractable nuclear Ab panel - Serum

1.08

0.07

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.06

0.07

1.4

1.3

275.8

151.3

nmol/l

—

(3024731) MCV [Entitic volume]

3108

31109

0.98

0.06

34.5

19.6

92.3

90.9

47.80

3073

30739

(3035941) MCH [Entitic mass]

3108

31108

0.98

0.06

34.5

19.5

30.7

30.3

18.31

3072

30735

(3021387) Prolactin [Units/volume] in Serum or Plasma

1001

0.98

0.06

1.6

341.6

292.6

mu/l

0.89

905

(3036071) Salmonella sp Ab [Titer] in Serum

110

1.09

0.05

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

201

0.94

0.04

1.1

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

125

1268

0.99

0.04

1.4

1.3

28.6

28.8

iu/l

0.02

1076

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

259

1.04

0.04

1.1

1.5

22.4

32.4

0.90

156

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

180

1.06

0.04

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

746

1.02

0.03

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

199

0.95

0.03

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

199

0.95

0.03

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

199

0.95

0.03

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1025

10276

1.00

0.03

4.1

3.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

750

0.99

0.02

1.4

—

(3007461) Platelets [#/volume] in Blood

3108

31092

0.99

0.02

34.8

19.6

267.4

251.0

e9/l

31.95

3068

30385

(40768795) Lymph node Pathology biopsy report

267

0.97

0.01

1.1

1.2

—

(3000012) Reticulocyte production index

136

0.96

0.00

1.3

1.6

—

(4027681)

186

0.97

0.00

1.2

—

(3018572) Chloride [Moles/volume] in Blood

606

0.99

0.00

7.8

102.9

105.3

mmol/l

2.15

540

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

202

0.99

0.00

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

202

0.99

0.00

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

202

0.99

0.00

1.1

—

(3039000) Anion gap in Blood

605

0.99

0.00

7.8

10.8

11.5

mmol/l

0.54

539

(3003888) Timothy IgE Ab [Units/volume] in Serum

476

1.01

0.00

1.0

1.1

9.3

4.6

u/ml

0.46

237

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

139

1.01

0.00

1.0

—

(3022621) pH of Urine by Test strip

171

1706

1.00

0.00

3.9

2.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

458

1.00

0.00

1.0

1.1

2.5

1.3

u/ml

0.21

188

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

196

1.02

0.00

1.9

2.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

397

1.01

0.00

1.1

3.8

3.0

u/ml

0.10

191

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.3

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

52.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1289.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.94

0.00

1.0

1.1

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

0.96

0.00

1.0

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.02

0.00

10.8

7.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

65.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.93

0.00

1.6

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint SMOKING_DEPEND and mortality.

Females

Parameter	HR [95% CI]	p-value
SMOKING_DEPEND	4.286 [3.7, 4.96]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.387

During the follow-up period (1.1.1998 — 31.12.2019), 1128 out of 7610 females with SMOKING_DEPEND died.

Males

Parameter	HR [95% CI]	p-value
SMOKING_DEPEND	4.225 [3.68, 4.85]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2408 out of 9115 males with SMOKING_DEPEND died.

Mortality risk

Mortality risk for people of age

years, who have SMOKING_DEPEND.

N-year risk	Females	Males
1	0.4%	0.781%
5	2.348%	4.83%
10	6.354%	10.518%
15	12.486%	19.903%
20	21.332%	31.389%

Relationships between endpoints

↥

Index endpoint: SMOKING_DEPEND – Smoking dependency

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Smoking dependency

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints